UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $239,560 | -46.9% | 20,904 | -6.8% | 0.00% | -50.0% |
Q1 2023 | $451,519 | -63.1% | 22,419 | -58.5% | 0.01% | -25.0% |
Q4 2022 | $1,224,362 | +90.7% | 54,008 | +57.8% | 0.01% | -11.1% |
Q3 2022 | $642,000 | +11.3% | 34,229 | +10.6% | 0.01% | +12.5% |
Q2 2022 | $577,000 | -3.7% | 30,939 | -6.7% | 0.01% | +14.3% |
Q1 2022 | $599,000 | -13.7% | 33,144 | -0.9% | 0.01% | 0.0% |
Q4 2021 | $694,000 | – | 33,459 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |